Physician profile
Deepak K Stokes
NPI 1528066206
$1,603.88
in general payments reported to CMS, 2019-2025
17 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $395 · 2021: $82.64 · 2022: $284 · 2023: $205 · 2024: $236 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Education: $110 · Gift: $28.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.65 |
| Education | $110.22 |
| Gift | $28.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $345.27 | 2020-2022 | |
| Becton, Dickinson and Company | $201.98 | 2019 | |
| Astellas Pharma US INC | $174.59 | 2023-2024 | Veozah |
| Davol INC. | $164.82 | 2020-2022 | |
| Medtronic, INC. | $131.00 | 2023-2025 | Symplicity G3, Ligasure, Onyx Frontier |
| Pfizer INC. | $127.54 | 2020-2023 | |
| Sumitomo Pharma America, INC. | $123.25 | 2023-2025 | Myfembree |
| Medtronic Vascular, INC. | $63.67 | 2020 | |
| Organon LLC | $60.99 | 2022-2025 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $38.90 | 2019-2020 | |
| Caldera Medical, INC | $28.88 | 2023 | Desara |
| Allergan, INC. | $28.05 | 2021 | |
| Biogen, INC. | $27.22 | 2025 | Zurzuvae |
| Octapharma USA, INC. | $27.22 | 2025 | Fibryga |
| Abbott Laboratories | $25.10 | 2024 | Freestyle Libre 3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.83 | 2022 | |
| Hologic INC | $17.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.